Pacific Biosciences of California (MEX:PACB) Total Equity: MXN43 Mil (As of Mar. 2026)


MEX:PACB Pacific Biosciences of California Inc MEX:PACB
53 GF Score
Price MXN27.50
GF Value MXN27.00
! 8 Warning Signs
View Full Analysis

What is Pacific Biosciences of California Total Equity?

Pacific Biosciences of California MEX:PACB 53 Total Equity is MXN43 Mil as of Mar. 2026. GuruFocus rates MEX:PACB with a GF Score™ of 53/100 and a GF Value™ of MXN27.00. The stock has 8 warning signs investors should review.

Pacific Biosciences of California's total equity for the quarter that ended in Mar. 2026 was MXN43 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Pacific Biosciences of California Total Equity Historical Data

* Premium members only.

The historical data trend for Pacific Biosciences of California's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pacific Biosciences of California Total Equity Chart

Pacific Biosciences of California Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 16,226.31 10,974.38 11,904.11 10,565.37 96.31

Pacific Biosciences of California Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,874.75 1,157.79 662.04 96.31 42.67
MEX:PACB
53GF Score
Pacific Biosciences of California Inc MEX:PACB
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Pacific Biosciences of California Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Pacific Biosciences of California's Total Equity for the fiscal year that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=14117.963-14021.651
=96

Pacific Biosciences of California's Total Equity for the quarter that ended in Mar. 2026 is calculated as

Total Equity=Total Assets(Q: Mar. 2026 )-Total Liabilities(Q: Mar. 2026 )
=14108.153-14065.488
=43

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of MXN43 Mil mean?
Pacific Biosciences of California (MEX:PACB) has a Total Equity of MXN43 Mil as of Mar. 2026. The total amount of equity as record on a company's balance sheet. View historical data for Pacific Biosciences of California and its competitors.
Is Pacific Biosciences of California's Total Equity too high?
Pacific Biosciences of California's current Total Equity is MXN43 Mil. Overall, Pacific Biosciences of California has a GF Score™ of 53/100, reflecting its overall financial health beyond just this single metric.
How does Pacific Biosciences of California's Total Equity compare to KIDS and MOBI?
Pacific Biosciences of California's Total Equity of MXN43 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Medical Devices & Instruments company?
A good Total Equity depends on the Medical Devices & Instruments industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Pacific Biosciences of California and its competitors. Pacific Biosciences of California's current Total Equity is MXN43 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pacific Biosciences of California stock overvalued right now?
Pacific Biosciences of California (MEX:PACB) has a current Total Equity of MXN43 Mil. The stock's GF Value™ is MXN27.00, compared to a current price of MXN27.50 — trading 1.9% above its estimated fair value. The current Total Equity is MXN43 Mil. Pacific Biosciences of California's overall GF Score™ is 53/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Pacific Biosciences of California (MEX:PACB), the current Total Equity is MXN43 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Pacific Biosciences of California (MEX:PACB) Overvalued in 2026?

Based on GuruFocus' analysis, Pacific Biosciences of California stock appears to be overvalued. The current stock price of MXN27.50 is trading 1.9% above its estimated GF Value™ of MXN27.00.

Key valuation signals for MEX:PACB:

  • Total Equity: MXN43 Mil
  • GF Value™: MXN27.00 vs. price of MXN27.50 (1.9% above fair value)
  • GF Score™: 53/100 with 8 warning signs

No single metric tells the full story. See the MEX:PACB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Pacific Biosciences of California Business Description

Other Exchanges PACB:USAP09:Germany
Address 1305 O’Brien Drive, Menlo Park, CA, USA, 94025
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Europe Middle East, and Africa and Asia-Pacific.
53GF Score

Get the complete analysis for MEX:PACB

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN27.50
Price
MXN27.00
GF Value